Inside the Acquisition Engine — Karuna, Mirati, RayzeBio, MyoKardia, Celgene

BMS's recent strategic posture is essentially "buy the science." Understanding the acquisition history — and what each deal added to the pipeline — gives candidates the strategic context to discuss BMS's moves intelligently. This module covers five key acquisitions and what they signal about BMS's future direction and how teams integrate.